Ligand to Report First Quarter 2024 Financial Results on May 7, 2024
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced that it will report first quarter 2024 financial results after the close of the U.S. financial markets on Tuesday, May 7, 2024, and will hold a
BusinesswireApr 23 08:31 ET
J&J Sets Guidance Below Consensus as MedTech Underperforms
Seeking AlphaApr 16 07:20 ET
Express News | Benchmark Reiterates Buy on Ligand Pharmaceuticals, Maintains $95 Price Target
Moomoo 24/7Apr 12 09:14 ET
While Shareholders of Ligand Pharmaceuticals (NASDAQ:LGND) Are in the Red Over the Last Three Years, Underlying Earnings Have Actually Grown
While it may not be enough for some shareholders, we think it is good to see the Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) share price up 12% in a single quarter. But that doesn't help the
Simply Wall StApr 11 09:59 ET
Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference
Captisol-enabled Topiramate Injection shown to be a substitute for an oral dose on a one-to-one basis Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced that its partners at the University of
BusinesswireApr 8 08:15 ET
Ligand Pharmaceuticals (LGND) Stock Dips While Market Gains: Key Facts
Yahoo FinanceApr 5 18:00 ET
Ovid Therapeutics Gains on Bullish View at Wedbush
Seeking AlphaApr 5 13:53 ET
Ligand Pharmaceuticals Launches Biopharmaceutical Company Pelthos Therapeutics
Seeking AlphaApr 3 09:23 ET
Ligand Pharmaceuticals Announces Launch Of Pelthos Therapeutics To Accelerate Commercialization Of ZELSUVMI, Scott Plesha Named CEO
Pharmaceutical executive Scott Plesha named CEOLead product ZELSUVMI expected to be commercially available in late 2024Ligand Pharmaceuticals (NASDAQ:LGND) today announced the launch of Pelthos Therap
BenzingaApr 3 09:05 ET
Ligand Pharmaceuticals (LGND) Ascends While Market Falls: Some Facts to Note
Yahoo FinanceApr 1 18:15 ET
Ligand Pharmaceuticals Gains Amid Bullish Investor Pitch
Seeking AlphaMar 27 15:53 ET
Here Is What to Know Beyond Why Ligand Pharmaceuticals Incorporated (LGND) Is a Trending Stock
Yahoo FinanceMar 21 09:00 ET
Ligand Pharmaceuticals (LGND) Exceeds Market Returns: Some Facts to Consider
Yahoo FinanceMar 20 18:00 ET
Ligand Pharmaceuticals (LGND) Declines More Than Market: Some Information for Investors
Yahoo FinanceMar 14 18:00 ET
Ligand Pharmaceuticals (LGND) Gains As Market Dips: What You Should Know
Yahoo FinanceMar 8 18:00 ET
Ligand Pharmaceuticals(LGND.US) Director Sells US$140.65K in Common Stocks
$Ligand Pharmaceuticals(LGND.US)$ Director Sabba Stephen L sold 1,893 shares of Common Stocks on Mar 5, 2024 at an average price of $74.3 for a total value of $140.65K.Source: Announcement What is sta
moomoo NewsMar 7 14:09 ET
Ligand Pharmaceuticals to Present at Barclays 26th Annual Global Healthcare Conference
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will participate in a fireside chat at the Barclays 26th Annual Global
BusinesswireMar 5 16:01 ET
Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced that effective March 1, 2024, Ligand's Human Capital Management and Compensation Committee approved the grant of a non-qualified stock option award to
BusinesswireMar 4 08:00 ET
Ligand Pharmaceuticals Inc's New Competition Risk – A Cause for Worry?
TipRanksMar 2 01:06 ET
Ligand Pharmaceuticals(LGND.US) Officer Sells US$12,384.4 in Common Stocks
$Ligand Pharmaceuticals(LGND.US)$ Officer Espinoza Octavio sold 140 shares of Common Stocks on Feb 28, 2024 at an average price of $88.46 for a total value of $12,384.4.Source: Announcement What is st
moomoo NewsFeb 29 19:32 ET
No Data
No Data